8-K: TruBridge Reports Mixed Q2 Results with Revenue Growth and Increased Bookings

TruBridge announced its second quarter 2024 financial results, showing a slight increase in total revenue and a significant rise in bookings, but a net loss.

Summary

• TruBridge reported a total revenue of $84.7 million for the second quarter of 2024, a slight increase from $84.6 million in the same period last year.
• Revenue Cycle Management (RCM) revenue saw a significant increase, reaching $54.1 million compared to $47.8 million in the prior year, now representing 63.9% of total revenue.
• The company experienced a GAAP loss per diluted share of $(0.34), compared to a loss of $(0.20) in the second quarter of 2023.
• Non-GAAP earnings per diluted share were $0.16, a decrease from $0.40 in the prior year.
• Adjusted EBITDA increased to $12.6 million, up from $11.2 million in the same quarter last year.
• Total bookings for the quarter were $23.3 million, compared to $21.0 million in the second quarter of 2023.
• TruBridge is reiterating its full-year 2024 guidance, expecting total revenue between $330 million and $340 million and adjusted EBITDA between $45 million and $50 million.

Sentiment

Score: 6

Explanation: The sentiment is mixed. While there are positive aspects like increased bookings and adjusted EBITDA, the GAAP loss and decrease in non-GAAP earnings per share temper the overall outlook. The reiteration of guidance is a positive sign, but the negative earnings results are a concern.

Positives

• TruBridge experienced growth in total bookings and RCM revenue.
• Adjusted EBITDA saw an increase year-over-year.
• The company reaffirmed its financial guidance for the full year.
• There was a significant improvement in cash flow from operations.
• The company's pipeline is healthy and they have a clear line of sight for the remainder of the year.

Negatives

• The company reported a GAAP loss per diluted share of $(0.34), which is worse than the $(0.20) loss in the same quarter last year.
• Non-GAAP earnings per diluted share decreased to $0.16, down from $0.40 in the prior year.
• EHR revenue decreased from $36.8 million to $30.6 million year over year.

Risks

• The company faces risks related to market saturation and hospital consolidations.
• Unfavorable economic conditions could lead to decreased spending on information technology and services.
• The healthcare industry is subject to significant legislative and regulatory uncertainty.
• The company is exposed to liability for failure to comply with regulatory requirements.
• Pandemics and other public health crises could cause economic disruptions.
• There are risks associated with the transition to a subscription-based recurring revenue model and technology modernization.
• Competition from companies with greater resources is a concern.
• Potential acquisitions could be expensive and time-consuming.
• The company needs to attract and retain qualified personnel.
• There is a potential for delays in the development of markets for their RCM service offering.
• The company is implementing a new enterprise resource planning software solution which could cause disruption.
• International business activities expose the company to various laws and regulations.
• The company is exposed to potential litigation.
• Reliance on an international workforce could cause business disruptions.
• The use of artificial intelligence could expose the company to liability.
• Failure to develop new products or enhance current products could impact the business.
• Product failures could result in claims for medical and other losses.
• Breaches of security and viruses in their systems could harm their reputation.
• Failure to maintain customer satisfaction could impact the business.
• The company may not be able to convince customers to migrate to current or future releases of their products.
• The company may fail to maintain margins and service rates.
• An increase in service revenues, which have lower gross margins, could impact profitability.
• The company is exposed to liability if they provide inaccurate claims data to payors.
• There are risks associated with licensing software and providing services.
• The company depends on licenses of rights, products and services from third parties.
• Misappropriation of intellectual property rights could impact the business.
• Interruptions in power supply and telecommunications could disrupt the business.
• The company may not be able to secure additional financing on favorable terms.
• The company has substantial indebtedness and may incur additional debt in the future.
• There are pressures on cash flow to service outstanding debt.
• Restrictive terms of their credit agreement could impact current and future operations.
• Changes in financial accounting matters could impact the measurement of performance.
• Goodwill or intangible assets could become impaired.
• Quarterly financial performance could fluctuate due to the timing of customer installations.
• The company's stock price is volatile.
• Failure to maintain effective internal control over financial reporting is a risk.
• The company is vulnerable to significant damage from natural disasters.
• Market risks related to interest rate changes could impact the business.
• Macroeconomic conditions, including bank failures, could have a material adverse effect.

Future Outlook

TruBridge expects total revenue between $82 million and $85 million and adjusted EBITDA between $11.5 million and $13.5 million for the third quarter of 2024. The company reiterates its full-year 2024 guidance of total revenue between $330 million and $340 million and adjusted EBITDA between $45 million and $50 million.

Management Comments

• Chris Fowler, chief executive officer of TruBridge, Inc., stated, 'We are pleased with our second quarter performance, both operationally and financially.'
• Fowler also noted, 'The team continued to build on our bookings momentum and cross-selling efforts, while we further enhanced our financial operations.'
• Fowler concluded, 'Given the health of our pipeline and clear line of sight for the remainder of the year, we are reiterating guidance and are enthusiastic about our future outlook.'

Industry Context

The healthcare technology sector is experiencing a mix of growth and challenges, with companies focusing on revenue cycle management and digital health solutions. TruBridge's results reflect this trend, with strong RCM growth but some challenges in EHR revenue. The company's focus on technology-first solutions aligns with the industry's move towards digital transformation.

Comparison to Industry Standards

• TruBridge's RCM revenue growth of 13.3% year-over-year is a positive sign, indicating strong demand for their services. Companies like R1 RCM and Optum also focus on RCM and have seen similar growth in recent periods.
• The decrease in EHR revenue is a concern, as other companies in the EHR space, such as Cerner and Epic, continue to see growth, although they are much larger companies.
• TruBridge's adjusted EBITDA margin of 14.8% is comparable to other mid-sized healthcare technology companies, but there is room for improvement to reach the levels of larger, more established players.
• The company's bookings growth of 11% year-over-year is a positive indicator of future revenue potential, and is in line with the growth seen by other companies in the healthcare technology space.

Stakeholder Impact

• Shareholders may be concerned about the GAAP loss and decrease in non-GAAP earnings per share.
• Employees may be impacted by the ongoing business transformation initiative.
• Customers may benefit from the company's focus on technology-first solutions.
• Suppliers and creditors may be impacted by the company's financial performance.

Next Steps

• TruBridge will hold a conference call and live webcast to discuss second quarter 2024 results on Thursday, August 8, 2024, at 3:30 p.m. Central time/4:30 p.m. Eastern time.
• The company will continue to focus on its RCM offerings and cross-selling efforts.
• TruBridge will continue to implement its business transformation initiative.

Key Dates

Keywords

Healthcare Solutions, Revenue Cycle Management, RCM, EHR, Electronic Health Record, Adjusted EBITDA, Bookings, Financial Results, Healthcare Technology